{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:28:41Z","timestamp":1791664121707,"version":"4.3.4"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Extracellular nucleosides and nucleotides activate a group of G protein-coupled receptors (GPCRs) known as purinergic receptors, comprising adenosine and P2Y receptors. Furthermore, purinergic P2X ion channels are activated by ATP. These receptors are expressed in liver resident cells and play a critical role in maintaining liver function. In the normal physiology, these receptors regulate hepatic metabolic processes such as insulin responsiveness, glycogen and lipid metabolism, and bile secretion. In disease states, ATP and other nucleotides serve as danger signals and modulate purinergic responses in the cells. Recent studies have demonstrated that purinergic receptors play a significant role in the development of metabolic syndrome associated non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), fibrosis, hepatocellular carcinoma (HCC) and liver inflammation. In this concise review, we dissect the role of purinergic signaling in different liver resident cells involved in maintaining healthy liver function and in the development of the above-mentioned liver pathologies. Moreover, we discuss potential therapeutic strategies for liver diseases by targeting adenosine, P2Y and P2X receptors.<\/jats:p>","DOI":"10.3389\/fendo.2021.718429","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T06:42:33Z","timestamp":1628664153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Purinergic Signaling in Liver Pathophysiology"],"prefix":"10.3389","volume":"12","author":[{"given":"Shanu","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1970.tb10646.x","article-title":"Evidence That Adenosine Triphosphate or a Related Nucleotide Is the Transmitter Substance Released by Non-Adrenergic Inhibitory Nerves in the Gut","volume":"40","author":"Burnstock","year":"1970","journal-title":"Br J Pharmacol"},{"key":"B2","article-title":"Purinergic Nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"114393","DOI":"10.1016\/j.bcp.2020.114393","article-title":"Purinergic Signaling in Diabetes and Metabolism","volume":"187","author":"Jain","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mam.2016.12.001","article-title":"Adenosine Signaling in Diabetes Mellitus and Associated Cardiovascular and Renal Complications","volume":"55","author":"Peleli","year":"2017","journal-title":"Mol Aspects Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3613","article-title":"Immunity, Inflammation and Cancer: A Leading Role for Adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature13816","article-title":"Adenosine Activates Brown Adipose Tissue and Recruits Beige Adipocytes via A2A Receptors","volume":"516","author":"Gnad","year":"2014","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cmet.2020.06.006","article-title":"Adenosine\/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity","volume":"32","author":"Gnad","year":"2020","journal-title":"Cell Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-1101-6","article-title":"Adenosine\u2013a Physiological or Pathophysiological Agent","volume":"92","author":"Fredholm","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c130024","article-title":"Energy Metabolism in the Liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr Physiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2012.03.001","article-title":"Rhythmic Nucleotide Synthesis in the Liver: Temporal Segregation of Metabolites","volume":"1","author":"Fustin","year":"2012","journal-title":"Cell Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.18.9948","article-title":"Isolated Rat Hepatocytes can Signal to Other Hepatocytes and Bile Duct Cells by Release of Nucleotides","volume":"93","author":"Schlosser","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80374-8","article-title":"It\u2019s Swell to Have ATP in the Liver","volume":"33","author":"Dranoff","year":"2000","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.08.011","article-title":"Release of Small Transmitters Through Kiss-and-Run Fusion Pores in Rat Pancreatic Beta Cells","volume":"4","author":"MacDonald","year":"2006","journal-title":"Cell Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1620","article-title":"Regulated ATP Release From Astrocytes Through Lysosome Exocytosis","volume":"9","author":"Zhang","year":"2007","journal-title":"Nat Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature09413","article-title":"Pannexin 1 Channels Mediate \u2018Find-Me\u2019 Signal Release and Membrane Permeability During Apoptosis","volume":"467","author":"Chekeni","year":"2010","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature08296","article-title":"Nucleotides Released by Apoptotic Cells Act as a Find-Me Signal to Promote Phagocytic Clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800793105","article-title":"ATP Release Through Connexin Hemichannels and Gap Junction Transfer of Second Messengers Propagate Ca2+ Signals Across the Inner Ear","volume":"105","author":"Anselmi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2801","DOI":"10.1371\/journal.pone.0002801","article-title":"ATP Release From Vascular Endothelia Occurs Across Cx43 Hemichannels and is Attenuated During Hypoxia","volume":"3","author":"Faigle","year":"2008","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29932","article-title":"The Role of the CD39-CD73-Adenosine Pathway in Liver Disease","volume":"236","author":"Wang","year":"2021","journal-title":"J Cell Physiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"166013","DOI":"10.1016\/j.bbadis.2020.166013","article-title":"Vesicular ATP Release From Hepatocytes Plays a Role in the Progression of Nonalcoholic Steatohepatitis","volume":"1867","author":"Tatsushima","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1038\/s41598-021-83144-w","article-title":"Clodronate, an Inhibitor of the Vesicular Nucleotide Transporter, Ameliorates Steatohepatitis and Acute Liver Injury","volume":"11","author":"Hasuzawa","year":"2021","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80357-8","article-title":"Volume-Sensitive Purinergic Signaling in Human Hepatocytes","volume":"33","author":"Feranchak","year":"2000","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jhep.2009.10.005","article-title":"ATP Release After Partial Hepatectomy Regulates Liver Regeneration in the Rat","volume":"52","author":"Gonzales","year":"2010","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1038\/s41598-017-08583-w","article-title":"Inhibition of Connexin Hemichannels Alleviates non-Alcoholic Steatohepatitis in Mice","volume":"7","author":"Willebrords","year":"2017","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.12.013","article-title":"Protective Effect of Genetic Deletion of Pannexin1 in Experimental Mouse Models of Acute and Chronic Liver Disease","volume":"1864","author":"Willebrords","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-019-09680-3","article-title":"Purinergic Signaling in Hepatic Disease","volume":"15","author":"Velazquez-Miranda","year":"2019","journal-title":"Purinergic Signal"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.06.008","article-title":"Pathological Roles of Purinergic Signaling in the Liver","volume":"57","author":"Vaughn","year":"2012","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11302-013-9398-8","article-title":"Purinergic Signalling in the Liver in Health and Disease","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000360498","article-title":"Purinergic Signaling in Liver Disease","volume":"32","author":"Vaughn","year":"2014","journal-title":"Dig Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The Integrative Biology of Type 2 Diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The Liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"100165","DOI":"10.1016\/j.jhepr.2020.100165","article-title":"Purinergic Signalling in Liver Diseases: Pathological Functions and Therapeutic Opportunities","volume":"2","author":"Wang","year":"2020","journal-title":"JHEP Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1432-1033.1987.tb13304.x","article-title":"Actions of Extracellular UTP and ATP in Perfused Rat Liver. A Comparative Study","volume":"167","author":"Haussinger","year":"1987","journal-title":"Eur J Biochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1042\/bj2310797","article-title":"P2-Purinergic Control of Liver Glycogenolysis","volume":"231","author":"Keppens","year":"1985","journal-title":"Biochem J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1042\/bj2400367","article-title":"Characterization of the Liver P2-Purinoceptor Involved in the Activation of Glycogen Phosphorylase","volume":"240","author":"Keppens","year":"1986","journal-title":"Biochem J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90504-Y","article-title":"Characterization of the Purinoceptors Present in Rabbit and Guinea Pig Liver","volume":"182","author":"Keppens","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/hep.22035","article-title":"Characterization of Ionotrophic Purinergic Receptors in Hepatocytes","volume":"47","author":"Emmett","year":"2008","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.082743","article-title":"Regulation of Human Hepatocytes by P2Y Receptors: Control of Glycogen Phosphorylase, Ca2+, and Mitogen-Activated Protein Kinases","volume":"313","author":"Dixon","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.067744","article-title":"Regulation of Rat Hepatocyte Function by P2Y Receptors: Focus on Control of Glycogen Phosphorylase and Cyclic AMP by 2-Methylthioadenosine 5\u2019-Diphosphate","volume":"311","author":"Dixon","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1988.tb14450.x","article-title":"Stimulation of Thromboxane Release by Extracellular UTP and ATP From Perfused Rat Liver. Role of Icosanoids in Mediating the Nucleotide Responses","volume":"178","author":"Haussinger","year":"1988","journal-title":"Eur J Biochem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1042\/bj2830265","article-title":"Gluconeogenesis Stimulated by Extracellular ATP is Triggered by the Initial Increase in the Intracellular Ca2+ Concentration of the Periphery of Hepatocytes","volume":"283","author":"Koike","year":"1992","journal-title":"Biochem J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1985.tb09141.x","article-title":"Effects of ATP and Adenosine Addition on Activity of Oxoglutarate Dehydrogenase and the Concentration of Cytoplasmic Free Ca2+ in Rat Hepatocytes","volume":"151","author":"Staddon","year":"1985","journal-title":"Eur J Biochem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1991.261.6.R1522","article-title":"Inhibition of Gluconeogenesis by Extracellular ATP in Isolated Rat Hepatocytes","volume":"261","author":"Asensi","year":"1991","journal-title":"Am J Physiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1989.tb14843.x","article-title":"Stimulation by Insulin of Glycolysis in Cultured Hepatocytes is Attenuated by Extracellular ATP and Puromycin Through Purine-Dependent Inhibition of Phosphofructokinase 2 Activation","volume":"182","author":"Probst","year":"1989","journal-title":"Eur J Biochem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01299-2","article-title":"Regulation of Glycogen Metabolism in Hepatocytes Through Adenosine Receptors. Role of Ca2+ and cAMP","volume":"437","author":"Gonzalez-Benitez","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1996.270.4.G701","article-title":"Effects of Extracellular ATP on Hepatic Fatty Acid Metabolism","volume":"270","author":"Guzman","year":"1996","journal-title":"Am J Physiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.29777","article-title":"Disruption of Adenosine 2A Receptor Exacerbates NAFLD Through Increasing Inflammatory Responses and SREBP1c Activity","volume":"68","author":"Cai","year":"2018","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2012.12.006","article-title":"Chronic Pharmacological Activation of P2Y13 Receptor in Mice Decreases HDL-Cholesterol Level by Increasing Hepatic HDL Uptake and Bile Acid Secretion","volume":"1831","author":"Serhan","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23897","article-title":"P2Y13 Receptor is Critical for Reverse Cholesterol Transport","volume":"52","author":"Fabre","year":"2010","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2010.08.013","article-title":"Altered Lipoprotein Metabolism in P2Y13 Knockout Mice","volume":"1801","author":"Blom","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e008204","DOI":"10.1136\/bmjopen-2015-008204","article-title":"Identification of Reciprocal Causality Between non-Alcoholic Fatty Liver Disease and Metabolic Syndrome by a Simplified Bayesian Network in a Chinese Population","volume":"5","author":"Zhang","year":"2015","journal-title":"BMJ Open"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2021.04.008","article-title":"Links Between Metabolic Syndrome and Metabolic Dysfunction-Associated Fatty Liver Disease","volume":"32","author":"Lim","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.369","article-title":"Increase in Adenosine A1 Receptor Gene Expression in the Liver of Streptozotocin-Induced Diabetic Rats","volume":"19","author":"Liu","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2007.03.005","article-title":"Diabetes-Induced Alterations of Adenosine Receptors Expression Level in Rat Liver","volume":"83","author":"Grden","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00235.2013","article-title":"Purinergic Receptor X7 Is a Key Modulator of Metabolic Oxidative Stress-Mediated Autophagy and Inflammation in Experimental Nonalcoholic Steatohepatitis","volume":"305","author":"Das","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.02.010","article-title":"P2X7 Receptor-NADPH Oxidase Axis Mediates Protein Radical Formation and Kupffer Cell Activation in Carbon Tetrachloride-Mediated Steatohepatitis in Obese Mice","volume":"52","author":"Chatterjee","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2005.05.032","article-title":"Activation of A2A Adenosine Receptor Attenuates Intestinal Inflammation in Animal Models of Inflammatory Bowel Disease","volume":"129","author":"Odashima","year":"2005","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00310.2005","article-title":"Adenosine A2A Receptor Activation Attenuates Inflammation and Injury in Diabetic Nephropathy","volume":"290","author":"Awad","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.1.21","article-title":"Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the Gs Protein-Coupled A2A Adenosine Receptor In Vivo","volume":"173","author":"Lukashev","year":"2004","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/JOE-19-0198","article-title":"Mice Lacking Adenosine 2A Receptor Reveal Increased Severity of MCD-Induced NASH","volume":"243","author":"Zhou","year":"2019","journal-title":"J Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1042\/CS20110504","article-title":"Adenosine A2a Receptor Stimulation Prevents Hepatocyte Lipotoxicity and non-Alcoholic Steatohepatitis (NASH) in Rats","volume":"123","author":"Imarisio","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trsl.2016.11.009","article-title":"Adenosine A2a Receptor Stimulation Blocks Development of Nonalcoholic Steatohepatitis in Mice by Multilevel Inhibition of Signals That Cause Immunolipotoxicity","volume":"182","author":"Alchera","year":"2017","journal-title":"Transl Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37409","article-title":"Adenosine Signaling Contributes to Ethanol-Induced Fatty Liver in Mice","volume":"119","author":"Peng","year":"2009","journal-title":"J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1070","article-title":"Links Between Insulin Resistance, Adenosine A2B Receptors, and Inflammatory Markers in Mice and Humans","volume":"60","author":"Figler","year":"2011","journal-title":"Diabetes"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.057596","article-title":"A2b Adenosine Receptor Regulates Hyperlipidemia and Atherosclerosis","volume":"125","author":"Koupenova","year":"2012","journal-title":"Circulation"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0573","article-title":"A2B Adenosine Receptors Prevent Insulin Resistance by Inhibiting Adipose Tissue Inflammation via Maintaining Alternative Macrophage Activation","volume":"63","author":"Csoka","year":"2014","journal-title":"Diabetes"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e40584","DOI":"10.1371\/journal.pone.0040584","article-title":"The A2b Adenosine Receptor Modulates Glucose Homeostasis and Obesity","volume":"7","author":"Johnston-Cox","year":"2012","journal-title":"PLoS One"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-020-09715-0","article-title":"Design and In Vivo Activity of A3 Adenosine Receptor Agonist Prodrugs","volume":"16","author":"Suresh","year":"2020","journal-title":"Purinergic Signal"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4364","article-title":"The A3 Adenosine Receptor Agonist, Namodenoson, Ameliorates Nonalcoholic Steatohepatitis in Mice","volume":"44","author":"Fishman","year":"2019","journal-title":"Int J Mol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2006578117","article-title":"Lack of Adipocyte Purinergic P2Y6 Receptor Greatly Improves Whole Body Glucose Homeostasis","volume":"117","author":"Jain","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e146577","DOI":"10.1172\/jci.insight.146577","article-title":"Adipocyte P2Y14 Receptors Play a Key Role in Regulating Whole-Body Glucose and Lipid Homeostasis","volume":"6","author":"Jain","year":"2021","journal-title":"JCI Insight"},{"key":"B73","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver Inflammation and Fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00069","article-title":"Activation of Adenosine Receptor A2A Increases HSC Proliferation and Inhibits Death and Senescence by Down-Regulation of P53 and Rb","volume":"5","author":"Ahsan","year":"2014","journal-title":"Front Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e69114","DOI":"10.1371\/journal.pone.0069114","article-title":"Adenosine 2A Receptor Antagonist Prevented and Reversed Liver Fibrosis in a Mouse Model of Ethanol-Exacerbated Liver Fibrosis","volume":"8","author":"Chiang","year":"2013","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.112250","article-title":"Effect of a Specific and Selective A(2B) Adenosine Receptor Antagonist on Adenosine Agonist AMP and Allergen-Induced Airway Responsiveness and Cellular Influx in a Mouse Model of Asthma","volume":"320","author":"Mustafa","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00294.2003","article-title":"Expression of P2Y Nucleotide Receptors and Ectonucleotidases in Quiescent and Activated Rat Hepatic Stellate Cells","volume":"287","author":"Dranoff","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.12.017","article-title":"Purinergic P2X7 Receptor Mediates Acetaldehyde-Induced Hepatic Stellate Cells Activation via PKC-Dependent GSK3beta Pathway","volume":"43","author":"Wu","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/mmr.2013.1807","article-title":"P2X7 Blockade Attenuates Mouse Liver Fibrosis","volume":"9","author":"Huang","year":"2014","journal-title":"Mol Med Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.020","article-title":"The P2X4 Purinergic Receptor Regulates Hepatic Myofibroblast Activation During Liver Fibrogenesis","volume":"69","author":"Le Guilcher","year":"2018","journal-title":"J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2007.10.003","article-title":"Activity and Expression of Ecto-5\u2019-Nucleotidase\/CD73 are Increased During Phenotype Conversion of a Hepatic Stellate Cell Line","volume":"82","author":"Andrade","year":"2008","journal-title":"Life Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00015.2012","article-title":"Activated Hepatic Stellate Cells Upregulate Transcription of Ecto-5\u2019-Nucleotidase\/CD73 via Specific SP1 and SMAD Promoter Elements","volume":"303","author":"Fausther","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-100685","article-title":"Ecto-5\u2019-Nucleotidase (CD73) -Mediated Extracellular Adenosine Production Plays a Critical Role in Hepatic Fibrosis","volume":"22","author":"Peng","year":"2008","journal-title":"FASEB J"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i39.4436","article-title":"Carcinogenesis on the Background of Liver Fibrosis: Implications for the Management of Hepatocellular Cancer","volume":"24","author":"O\u2019Rourke","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-013-9369-0","article-title":"High Dose of Extracellular ATP Switched Autophagy to Apoptosis in Anchorage-Dependent and Anchorage-Independent Hepatoma Cells","volume":"9","author":"Wei","year":"2013","journal-title":"Purinergic Signal"},{"key":"B87","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/1743-422X-8-431","article-title":"Identification of Ionotrophic Purinergic Receptors in Huh-7 Cells and Their Response Towards Structural Proteins of HCV Genotype 3a","volume":"8","author":"Manzoor","year":"2011","journal-title":"Virol J"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6240","article-title":"P2X3 Purinergic Receptor Overexpression Is Associated With Poor Recurrence-Free Survival in Hepatocellular Carcinoma Patients","volume":"6","author":"Maynard","year":"2015","journal-title":"Oncotarget"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16191","article-title":"Carcinoma-Specific Expression of P2Y11 Receptor and its Contribution in ATP-Induced Purinergic Signalling and Cell Migration in Human Hepatocellular Carcinoma Cells","volume":"8","author":"Khalid","year":"2017","journal-title":"Oncotarget"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.540047","article-title":"The P2Y2 Nucleotide Receptor Mediates the Proliferation and Migration of Human Hepatocellular Carcinoma Cells Induced by ATP","volume":"289","author":"Xie","year":"2014","journal-title":"J Biol Chem"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25989","article-title":"Disordered Purinergic Signaling and Abnormal Cellular Metabolism are Associated With Development of Liver Cancer in Cd39\/ENTPD1 Null Mice","volume":"57","author":"Sun","year":"2013","journal-title":"Hepatology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-019-0724-7","article-title":"CD73 Promotes Hepatocellular Carcinoma Progression and Metastasis via Activating PI3K\/AKT Signaling by Inducing Rap1-Mediated Membrane Localization of P110beta and Predicts Poor Prognosis","volume":"12","author":"Ma","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27694","article-title":"Ecto-5\u2019-Nucleotidase (CD73) is a Potential Target of Hepatocellular Carcinoma","volume":"234","author":"Shali","year":"2019","journal-title":"J Cell Physiol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000008","article-title":"The A3 Adenosine Receptor Agonist CF102 Induces Apoptosis of Hepatocellular Carcinoma via De-Regulation of the Wnt and NF-KappaB Signal Transduction Pathways","volume":"33","author":"Bar-Yehuda","year":"2008","journal-title":"Int J Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22593","article-title":"CF102 an A3 Adenosine Receptor Agonist Mediates Anti-Tumor and Anti-Inflammatory Effects in the Liver","volume":"226","author":"Cohen","year":"2011","journal-title":"J Cell Physiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00124","article-title":"Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development","volume":"13","author":"Jacobson","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1039\/C7MD00397H","article-title":"Pyrimidine Nucleotides Containing a (S)-Methanocarba Ring as P2Y6 Receptor Agonists","volume":"8","author":"Toti","year":"2017","journal-title":"Medchemcomm"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00164","article-title":"Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5\u2019-Nucleotidase (CD73) Inhibitors","volume":"62","author":"Junker","year":"2019","journal-title":"J Med Chem"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00745","article-title":"Exploration of Alternative Scaffolds for P2Y14 Receptor Antagonists Containing a Biaryl Core","volume":"63","author":"Jung","year":"2020","journal-title":"J Med Chem"},{"key":"B100","doi-asserted-by":"publisher","first-page":"128008","DOI":"10.1016\/j.bmcl.2021.128008","article-title":"Structure Activity Relationship of 3-Nitro-2-(Trifluoromethyl)-2H-Chromene Derivatives as P2Y6 Receptor Antagonists","volume":"41","author":"Jung","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00164","article-title":"Structure-Activity Relationship of Heterocyclic P2Y14 Receptor Antagonists: Removal of the Zwitterionic Character With Piperidine Bioisosteres","volume":"64","author":"Jung","year":"2021","journal-title":"J Med Chem"},{"key":"B102","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-90808-3_4","volume-title":"A1 Adenosine Receptor Agonists, Antagonists, and Allosteric Modulators","author":"Gao","year":"2018"},{"key":"B103","doi-asserted-by":"publisher","first-page":"128137","DOI":"10.1016\/j.bmcl.2021.128137","article-title":"Structure-Activity Relationships of Pyrimidine Nucleotides Containing a 5\u2019-Alpha,Beta-Methylene Diphosphonate at the P2Y6 Receptor","volume":"45","author":"Oliva","year":"2021","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.718429\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T06:42:38Z","timestamp":1628664158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.718429\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":103,"alternative-id":["10.3389\/fendo.2021.718429"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.718429","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"article-number":"718429"}}